| 000 | 01809 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518051051.0 | ||
| 264 | 0 | _c20200608 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1533-4023 | ||
| 024 | 7 |
_a10.1097/FJC.0000000000000697 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMishra, Abhishek | |
| 245 | 0 | 0 |
_aAntithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. _h[electronic resource] |
| 260 |
_bJournal of cardiovascular pharmacology _c08 2019 |
||
| 300 |
_a82-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 |
_aAtrial Fibrillation _xdiagnosis |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xdiagnosis |
| 650 | 0 | 4 |
_aCoronary Thrombosis _xdiagnosis |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPercutaneous Coronary Intervention _xadverse effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aStents |
| 650 | 0 | 4 |
_aStroke _xdiagnosis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSingh, Maninder | |
| 700 | 1 | _aAcker, Warren W | |
| 700 | 1 | _aKamboj, Sukriti | |
| 700 | 1 | _aSporn, Daniel | |
| 700 | 1 | _aStapleton, Dwight | |
| 700 | 1 | _aKaluski, Edo | |
| 773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 74 _gno. 2 _gp. 82-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/FJC.0000000000000697 _zAvailable from publisher's website |
| 999 |
_c29901942 _d29901942 |
||